Dr. Thompson on the Future of Treatment in Multiple Myeloma

Michael A. Thompson, MD, PhD
Published: Thursday, Mar 23, 2017



Michael A. Thompson, MD, PhD, medical director, precision medicine, Vince Lombardi Cancer Clinic, Aurora Health Care, discusses the future of treatment in multiple myeloma.

Immunotherapy may be beneficial in patients with later stages of multiple myeloma, says Thompson. Combinations with checkpoint inhibitors are currently being explored.

For patients with early disease that have a high risk of progressing from smoldering myeloma to myeloma, a combination of induction, consolidation, and maintenance may be curative, adds Thompson.
 
SELECTED
LANGUAGE


Michael A. Thompson, MD, PhD, medical director, precision medicine, Vince Lombardi Cancer Clinic, Aurora Health Care, discusses the future of treatment in multiple myeloma.

Immunotherapy may be beneficial in patients with later stages of multiple myeloma, says Thompson. Combinations with checkpoint inhibitors are currently being explored.

For patients with early disease that have a high risk of progressing from smoldering myeloma to myeloma, a combination of induction, consolidation, and maintenance may be curative, adds Thompson.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of ImmunotherapyAug 13, 20191.5
Publication Bottom Border
Border Publication
x